|
Name |
1-Aziridineethanamine
|
Molecular Formula | C4H10N2 | |
IUPAC Name* |
2-(aziridin-1-yl)ethanamine
|
|
SMILES |
C1CN1CCN
|
|
InChI |
InChI=1S/C4H10N2/c5-1-2-6-3-4-6/h1-5H2
|
|
InChIKey |
LSDGFGPIFBOTJI-UHFFFAOYSA-N
|
|
Synonyms |
1-Aziridineethanamine; 4025-37-0; 2-(aziridin-1-yl)ethanamine; 2-(aziridin-1-yl)ethan-1-amine; (2-Aziridinylethyl)amine; 1-(2-Aminoethyl)aziridine; N-(2-Aminoethyl)aziridine; 1-(2-Aminoethyl)ethylenimine; Aziridine, 1-(2-aminoethyl)-; N-(.beta.-Aminoethyl)ethylenimine; N-(beta-Aminoethyl)ethylenimine; 2-(Aziridin-1-yl)ethanamineHCl; NSC 145379; Aziridine, 1-(2-aminoethyl)- (8CI); 2-(aziridin-1-yl)ethanamine hydrochloride; AI3-50413; 1-(2-aminoethyl) aziridine; 1-(2-Aminoethyl)- aziridine; 2-(AZIRIDIN)ETHANAMINE; 2-(1-Aziridinyl)ethanamine #; DTXSID00193229; NSC145379; ZINC19366615; AKOS006274586; NSC-145379; PB48042; DB-069974; A6733; CS-0170824; FT-0652017; P18027
|
|
CAS | 4025-37-0 | |
PubChem CID | 97697 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 86.14 | ALogp: | -0.9 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 29.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 6 | QED Weighted: | 0.469 |
Caco-2 Permeability: | -5.103 | MDCK Permeability: | 0.00008140 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.016 |
Human Intestinal Absorption (HIA): | 0.018 | 20% Bioavailability (F20%): | 0.019 |
30% Bioavailability (F30%): | 0.043 |
Blood-Brain-Barrier Penetration (BBB): | 0.433 | Plasma Protein Binding (PPB): | 9.49% |
Volume Distribution (VD): | 1.476 | Fu: | 86.63% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.098 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.791 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.331 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.893 |
CYP3A4-inhibitor: | 0.002 | CYP3A4-substrate: | 0.154 |
Clearance (CL): | 6.779 | Half-life (T1/2): | 0.401 |
hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.089 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.109 |
Rat Oral Acute Toxicity: | 0.481 | Maximum Recommended Daily Dose: | 0.083 |
Skin Sensitization: | 0.881 | Carcinogencity: | 0.385 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.37 |
Respiratory Toxicity: | 0.952 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000579 | 0.222 | D0V0LB | 0.250 | ||||
ENC000914 | 0.185 | D0N3PE | 0.244 | ||||
ENC001201 | 0.163 | D01ZSO | 0.172 | ||||
ENC000244 | 0.161 | D0Y7XC | 0.167 | ||||
ENC001185 | 0.152 | D0Q4YK | 0.162 | ||||
ENC000895 | 0.152 | D0X5WJ | 0.161 | ||||
ENC000137 | 0.147 | D01UUD | 0.154 | ||||
ENC002744 | 0.146 | D04QLR | 0.149 | ||||
ENC000751 | 0.143 | D06RCB | 0.149 | ||||
ENC000123 | 0.135 | D01OUE | 0.147 |